ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ticagrelor versus clopidogrel in reducing inflammatory cell infiltration of thrombus aspirated in patients with ST-elevation myocardial infarction

Shen, Jing; Liu, Guangzhong; Wu, Guodong; Sheng, Lijian; Cao, Zhengyu; Guo, Shuyuan; Dong, Shaohong; Sun, Xin*; Tian, Ye*哈尔滨医科大学; 1; y
European Journal of Clinical Pharmacology2022-9DOI: 10.1007/s00228-022-03348-5
2被引7阅读
引用收藏
分享

摘要

Background Ticagrelor provides more rapid, potent, and consistent anti-platelet efficacy than clopidogrel. This randomized trial aimed to evaluate the anti-inflammation effects of ticagrelor versus clopidogrel on thrombus aspirated from the ST-elevation myocardial infarction (STEMI) patients. Method A total of 98 patients with STEMI and intended percutaneous coronary intervention (PCI) were randomly assigned to receive clopidogrel (600-mg loading dose) or ticagrelor (180-mg loading dose), of whom 55 with large thrombus burden underwent thrombus aspiration during PCI. Thrombus specimens were successfully aspirated from 49 patients. Finally, 24 patients in the clopidogrel group and 23 in the ticagrelor group completed the study. Inflammatory cells within thrombi were assessed by hematoxylin-eosin and immunohistochemistry stainings. Results Compared with the clopidogrel group, the number of total inflammatory cells per mm(2) thrombus area in the ticagrelor group was decreased by 28% (P = 0.009). The numbers of neutrophils and myeloperoxidase-positive cells per mm(2) thrombus area in the ticagrelor group were respectively decreased by 35% (P = 0.016) and 28% (P = 0.047), as compared with those in the clopidogrel group. Moreover, ticagrelor treatment reduced the ratio of monocytes number higher than 250 per mm(2) thrombus area compared with clopidogrel treatment (4% versus 29%, P = 0.048). Conclusion In patients with undergoing PCI for STEMI, the loading dose ticagrelor regimen was associated with a reduction in inflammatory cell infiltration within thrombus compared with the loading dose clopidogrel regimen.

学科与关键词

关键词
P2Y(12) receptorTicagrelorClopidogrelThrombusInflammation
相关
加载中…
  • Ticagrelor and the risk of infections during hospitalization in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
    Lian, Xing-Ji; Dai, Yi-Ning; Xue, Jin-Hua; Zeng, Li-Huan; Wang, Li-Tao; Xue, Ling; Chen, Ji-Yan; Tan, Ning; He, Peng-Cheng*; Liu, Yuan-Hui*; Duan, Chong-Yang*Atherosclerosis, 2021, 331: 6-11.被引 2
  • Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity: a randomized, crossover clinical study (SINGLE study)
    He, Meijiao; Yan, Wei; Zhang, Yun; Kong, Yihui; Han, Xuejie; Ren, Jie; Zhao, Zhongyang; Liu, Guangzhong; Shi, Jing*; Li, Yue*Platelets, 2022, 33(8): 1146-1152.被引 2
  • The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
    Woong Gil, Choi; Gi Chang, Kim; Cheol Ho, Lee; Hye Young, Kim; Dong Woon, KimThe Korean Journal of Internal Medicine, 2021, 36(2): 352-361.
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Clinical Pharmacology
发表日期
2022-09
卷期
第 78 卷, 第 9 期
页码
1391-1398
DOI
10.1007/s00228-022-03348-5
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Shenzhen Key Medical Discipline Construction Fund [szxk003]; Shenzhen People's Hospital Young College academic backbone to support project [SYJCYJ 202008]

作者

  • S

    Shen, Jing (第一作者)

    1 · 2

  • L

    Liu, Guangzhong

    1 · 2

查看全部 9 位作者收起作者
  • W

    Wu, Guodong

    1 · harbin med univ

  • S

    Sheng, Lijian

    1 · harbin med univ

  • C

    Cao, Zhengyu

    1 · harbin med univ

  • G

    Guo, Shuyuan

    1 · harbin med univ

  • D

    Dong, Shaohong

    1 · 2

  • S

    Sun, Xin (通讯)

    1 · 2

  • T

    Tian, Ye (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417